A major advance in cancer investigation is occurring with the use of mini-antibodies to re-engage damaged p53. This crucial tumor suppressor protein is frequently inactivated in many types of cancer, causing https://extrabookmarking.com/story21948082/nanobodies-reactivate-the-p53-protein-new-promising-approach-for-tumor-management